Bristol-Myers Squibb Company;Exelixis Patent Company LLC
发明人:
申请号:
EP14763091.7
公开号:
EP2968275B1
申请日:
2014.03.14
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present invention provides compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as modulators of liver X receptors (LXR), compositions comprising any of such novel compounds, methods of using these compounds or compositions as medicaments for prevention or treatment of diseases or disorders related to liver X receptor (LXR), as well as methods of preparing these LXR modulators and using them in the manufacture of medicaments.